Our findings suggest crosstalk between the SUMOylation system and the ER-signalling pathway, and that their complex interaction accounts for either the correct expression or overexpression of UBC9, the latter of which is associated with the development of breast cancer. This evidence concerns the gene UBE2I and breast cancer.